APO Research, Inc.

Global Cell Freezing Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Choose your research edition.

Compare the research focus and single-user price for each edition.
Research editionIndustry ResearchIndustry Growth & TrendsMarket StructureSelectedMarket Outlook & Growth OpportunitiesMarket Analysis & Forecast
Core differenceUnderstand the overall industry landscape, competition and leading companies.Examine growth drivers and how demand is developing across regional markets.Compare how the market is divided across companies, types and applications.Compare regional and country-level demand to assess geographic market opportunities.Assess market size, historical trends and forecasts for forward planning.
Single-user price$2,950 USD$3,450 USD$3,950 USD$4,250 USD$4,950 USD
Your choiceView editionView editionCurrent editionView editionView edition
View pricing & licenses

Cell Freezing Media are formulated aqueous cryopreservation preparations used to preserve the viability, structural integrity, biological characteristics, and functional recovery of living cells during controlled freezing, cryogenic storage, and subsequent thawing. Their protective mechanisms address the physical and biochemical stresses associated with extracellular ice formation, progressive solute concentration, osmotic dehydration, intracellular ice formation, membrane destabilization, and freezing induced cellular injury. Commercial formulations typically combine a buffered aqueous medium with permeating cryoprotective agents, nonpermeating osmolytes, electrolytes, carbohydrates, and selected macromolecular stabilizers. Dimethyl sulfoxide (DMSO) is the predominant permeating cryoprotectant in established commercial formulations, commonly incorporated at concentrations of 2% to 10%, depending on the cell type and intended freezing conditions. DMSO modifies the freezing behavior of intracellular and extracellular water and reduces ice associated cellular damage, while its concentration and exposure conditions must be balanced against cytotoxicity and osmotic stress. Commercial DMSO free formulations employ alternative cryoprotective systems, including combinations of polyols, sugars, polymers, and other stabilizing constituents. Serum containing, serum free, protein free, animal component free, and chemically defined formulations represent different compositional specifications within these product families. The physical products are predominantly sterile liquid preparations supplied as ready for use solutions or concentrated formulations in bottles, vials, and flexible bags, with manufacturing involving controlled formulation, dissolution, filtration, and aseptic filling. Product specifications vary with cell membrane permeability, sensitivity to cryoprotectants, required post thaw recovery, and subsequent biological functionality. Commercial applications include the cryopreservation of established mammalian cell lines, primary cells, hematopoietic cells, immune cells, mesenchymal stromal cells, embryonic stem cells, induced pluripotent stem cells, and selected multicellular cultures. These products are consumed in laboratory research, biological sample repositories, master and working cell bank preparation for biopharmaceutical manufacturing, and the preservation of cellular intermediates and final cell preparations used in cell therapy and regenerative medicine. Commercial supply encompasses formulated freezing media for research and industrial cell processing, including specialized preparations manufactured for clinical cell processing and therapeutic manufacturing.

Product & engineering

Understand the product.

Cell Freezing Media are formulated aqueous cryopreservation preparations used to preserve the viability, structural integrity, biological characteristics, and functional recovery of living cells during controlled freezing, cryogenic storage, and subsequent thawing. Their protective mechanisms address the physical and biochemical stresses associated with extracellular ice formation, progressive solute concentration, osmotic dehydration, intracellular ice formation, membrane destabilization, and freezing induced cellular injury. Commercial formulations typically combine a buffered aqueous medium with permeating cryoprotective agents, nonpermeating osmolytes, electrolytes, carbohydrates, and selected macromolecular stabilizers. Dimethyl sulfoxide (DMSO) is the predominant permeating cryoprotectant in established commercial formulations, commonly incorporated at concentrations of 2% to 10%, depending on the cell type and intended freezing conditions. DMSO modifies the freezing behavior of intracellular and extracellular water and reduces ice associated cellular damage, while its concentration and exposure conditions must be balanced against cytotoxicity and osmotic stress. Commercial DMSO free formulations employ alternative cryoprotective systems, including combinations of polyols, sugars, polymers, and other stabilizing constituents. Serum containing, serum free, protein free, animal component free, and chemically defined formulations represent different compositional specifications within these product families. The physical products are predominantly sterile liquid preparations supplied as ready for use solutions or concentrated formulations in bottles, vials, and flexible bags, with manufacturing involving controlled formulation, dissolution, filtration, and aseptic filling. Product specifications vary with cell membrane permeability, sensitivity to cryoprotectants, required post thaw recovery, and subsequent biological functionality. Commercial applications include the cryopreservation of established mammalian cell lines, primary cells, hematopoietic cells, immune cells, mesenchymal stromal cells, embryonic stem cells, induced pluripotent stem cells, and selected multicellular cultures. These products are consumed in laboratory research, biological sample repositories, master and working cell bank preparation for biopharmaceutical manufacturing, and the preservation of cellular intermediates and final cell preparations used in cell therapy and regenerative medicine. Commercial supply encompasses formulated freezing media for research and industrial cell processing, including specialized preparations manufactured for clinical cell processing and therapeutic manufacturing.

Selected research

Market Structure

Global Cell Freezing Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

MARKET AT A GLANCE

Scale & outlook

2025
279.46USD million
2032
568.98USD million
Market size · USD million
03006002025 · 279.46 USD million279.4620252026 · 310.86 USD million310.8620262032 · 568.98 USD million568.982032

Select a bar to inspect its value.

Source: APO Research, Inc.

Market perspective

According to APO Research, Inc, the global Cell Freezing Media market was valued at USD 279.46 million in 2025, is estimated to reach USD 310.86 million in 2026, and is projected to increase to USD 568.98 million by 2032, representing a compound annual growth rate (CAGR) of 10.60% from 2026 to 2032. Market expansion is primarily associated with increasing commercial cell therapy production, greater utilization of formulated cryopreservation media in biopharmaceutical cell banking, and the adoption of specialized formulations for clinically manufactured cellular products. Cell therapy manufacturing generates recurring demand through cell collection, expansion, intermediate freezing, and final product filling, with consumption determined by processed cell volumes, manufacturing batch frequency, and the amount of freezing medium required per cell preparation. Biopharmaceutical manufacturing uses these products for master and working cell banks, where demand is associated with new production cell lines, manufacturing process development, and periodic bank replenishment. Research laboratories and biorepositories contribute additional consumption as new cell lines and biological specimens enter storage, although established frozen inventories require limited additional freezing medium.

The commercialization of cell therapies has established a significant source of demand for qualified cryopreservation formulations, particularly in the United States. BioLife Solutions reported revenue of USD 96.2 million in 2025, with its CryoStor product family accounting for 82% of the total. The company's biopreservation media revenue increased by USD 19.3 million, or 30%, during 2025, primarily reflecting higher demand from customers with commercially approved therapies. As of June 30, 2026, BioLife reported that its biopreservation media were incorporated into 18 commercial cell and gene therapies and approximately 250 ongoing commercially sponsored clinical trials in the United States. Repligen completed its acquisition of BioLife in October 2026, consolidating an established clinical cryopreservation media business with its bioprocessing operations. Clinical adoption establishes formulation specific requirements for cell viability, recovery, residual cryoprotectant exposure, and manufacturing consistency. Once incorporated into a validated therapeutic manufacturing process, changes to freezing media can require additional compatibility studies and process qualification, influencing supplier continuity and the commercial value of established formulations.

DMSO containing media remain widely used for routine cell banking and the preservation of established mammalian cell lines, stem cells, and immune cells. Sartorius supplies NutriFreez D10 and D5 formulations containing 10% and 5% DMSO, respectively, addressing different cell preservation and clinical processing requirements. FUJIFILM offers PRIME XV FreezIS formulations with and without DMSO, including products intended for further therapeutic manufacturing. In China, Yocon Biotechnology supplies GMP grade DMSO free freezing media for mesenchymal stem cells and other cellular preparations, while Japan's ZENOGEN PHARMA supplies both conventional and DMSO free CELLBANKER formulations. The development of chemically defined, serum free, and animal component free products reflects the requirements of clinical manufacturing processes for controlled raw material composition and reproducible post thaw cell performance. Revenue growth is expected to derive principally from higher commercial consumption and a changing mix of research and clinical formulations. Realized selling prices remain dependent on formulation complexity, aseptic manufacturing requirements, packaging configurations, customer qualification requirements, and procurement volumes. Competition from established international manufacturers and regional suppliers is expected to constrain price increases in conventional formulations, while specialized products retain differentiated pricing based on their manufacturing specifications and approved customer applications.

Full market overview

This report provides an overview of the global Cell Freezing Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Freezing Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Freezing Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cell Freezing Media market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell Freezing Media Segment by Company

  • Thermo Fisher Scientific
  • Merck
  • Cytiva
  • Sartorius
  • FUJIFILM
  • BioLife Solutions
  • Lonza
  • STEMCELL Technologies
  • Miltenyi Biotec
  • Bio Techne
  • Avantor
  • HiMedia Laboratories
  • ZENOAQ
  • PAN Biotech
  • PromoCell
  • MP Biomedicals
  • ATCC
  • Teknova
  • Yocon Biotechnology
  • ExCell Bio
  • Shanghai BasalMedia
  • Dakewe
  • Cyagen Biosciences
  • Yeasen Biotechnology
  • Solarbio
  • Beyotime Biotechnology
  • Quality Biological
  • WELGENE
  • GC Lymphotec
  • Capricorn Scientific
  • Meilun Biotechnology
  • Nacalai Tesque
  • Saraya
  • ScienCell Research Laboratories
  • Cell Applications
  • Nanjing Sansheng Biotechnology
  • Pricella Biotechnology
  • CELLnTEC

Cell Freezing Media Segment by Type

  • DMSO Containing
  • DMSO Free

Cell Freezing Media Segment by Application

  • Research
  • Biobanking
  • Biopharmaceutical Manufacturing
  • Cell Therapy and Regenerative Medicine

Cell Freezing Media Segment by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Poland
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Southeast Asia
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Türkiye
    • GCC Countries

Study Objectives

  1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
  3. To split the breakdown data by regions, type, manufacturers, and Application.
  4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
  5. To identify significant trends, drivers, influence factors in global and regions.
  6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

  1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Freezing Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  2. This report will help stakeholders to understand the global industry status and trends of Cell Freezing Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
  3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  4. This report stays updated with novel technology integration, features, and the latest developments in the market.
  5. This report helps stakeholders to gain insights into which regions to target globally.
  6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Freezing Media.
  7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

  1. Chapter 1: Provides an overview of the Cell Freezing Media market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
  2. Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  3. Chapter 3: Detailed analysis of Cell Freezing Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
  4. Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  5. Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  6. Chapter 6: Sales of Cell Freezing Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
  7. Chapter 7: Revenue of Cell Freezing Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
  8. Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  9. Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
  10. Chapter 10: Concluding Insights of the report

More report detail

Tables and figures

List of Tables

  • Table 1. Cell Freezing Media Industry Trends
  • Table 2. Cell Freezing Media Industry Drivers
  • Table 3. Cell Freezing Media Industry Opportunities and Challenges
  • Table 4. Cell Freezing Media Industry Restraints
  • Table 5. Global Cell Freezing Media Revenue by Manufacturers (US$ Million) & (2021-2026)
  • Table 6. Global Cell Freezing Media Revenue Market Share by Manufacturers (2021-2026)
  • Table 7. Global Cell Freezing Media Sales by Manufacturers (L) & (2021-2026)
  • Table 8. Global Cell Freezing Media Sales Market Share by Manufacturers
  • Table 9. Global Cell Freezing Media Average Sales Price (USD/L) of Manufacturers (2021-2026)
  • Table 10. Global Cell Freezing Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  • Table 11. Global Cell Freezing Media Key Manufacturers Manufacturing Sites & Headquarters
  • Table 12. Global Cell Freezing Media Manufacturers, Product Type & Application
  • Table 13. Global Cell Freezing Media Manufacturers Establishment Date
  • Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 15. Global Cell Freezing Media by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
  • Table 16. Major Manufacturers of DMSO Containing
  • Table 17. Major Manufacturers of DMSO Free
  • Table 18. Global Cell Freezing Media Sales by Type 2021 VS 2025 VS 2032 (L)
  • Table 19. Global Cell Freezing Media Sales by Type (2021-2026) & (L)
  • Table 20. Global Cell Freezing Media Sales by Type (2027-2032) & (L)
  • Table 21. Global Cell Freezing Media Sales Market Share by Type (2021-2026)
  • Table 22. Global Cell Freezing Media Sales Market Share by Type (2027-2032)
  • Table 23. Global Cell Freezing Media Revenue by Type 2021 VS 2025 VS 2032 (L)
  • Table 24. Global Cell Freezing Media Revenue by Type (2021-2026) & (L)
  • Table 25. Global Cell Freezing Media Revenue by Type (2027-2032) & (L)
  • Table 26. Global Cell Freezing Media Revenue Market Share by Type (2021-2026)
  • Table 27. Global Cell Freezing Media Revenue Market Share by Type (2027-2032)
  • Table 28. Major Manufacturers of Research
  • Table 29. Major Manufacturers of Biobanking
  • Table 30. Major Manufacturers of Biopharmaceutical Manufacturing
  • Table 31. Major Manufacturers of Cell Therapy and Regenerative Medicine
  • Table 32. Global Cell Freezing Media Sales by Application 2021 VS 2025 VS 2032 (L)
  • Table 33. Global Cell Freezing Media Sales by Application (2021-2026) & (L)
  • Table 34. Global Cell Freezing Media Sales by Application (2027-2032) & (L)
  • Table 35. Global Cell Freezing Media Sales Market Share by Application (2021-2026)
  • Table 36. Global Cell Freezing Media Sales Market Share by Application (2027-2032)
  • Table 37. Global Cell Freezing Media Revenue by Application 2021 VS 2025 VS 2032 (L)
  • Table 38. Global Cell Freezing Media Revenue by Application (2021-2026) & (L)
  • Table 39. Global Cell Freezing Media Revenue by Application (2027-2032) & (L)
  • Table 40. Global Cell Freezing Media Revenue Market Share by Application (2021-2026)
  • Table 41. Global Cell Freezing Media Revenue Market Share by Application (2027-2032)
  • Table 42. Global Cell Freezing Media Sales by Region: 2021 VS 2025 VS 2032 (L)
  • Table 43. Global Cell Freezing Media Sales by Region (2021-2026) & (L)
  • Table 44. Global Cell Freezing Media Sales Market Share by Region (2021-2026)
  • Table 45. Global Cell Freezing Media Sales Forecasted by Region (2027-2032) & (L)
  • Table 46. Global Cell Freezing Media Sales Forecasted Market Share by Region (2027-2032)
  • Table 47. North America Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L)
  • Table 48. North America Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 49. North America Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 50. Europe Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L)
  • Table 51. Europe Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 52. Europe Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 53. Asia Pacific Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L)
  • Table 54. Asia Pacific Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 55. Asia Pacific Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 56. South America, Middle East and Africa Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L)
  • Table 57. South America, Middle East and Africa Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 58. South America, Middle East and Africa Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 59. Global Cell Freezing Media Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 60. Global Cell Freezing Media Revenue by Region (2021-2026) & (US$ Million)
  • Table 61. Global Cell Freezing Media Revenue by Region (2027-2032) & (US$ Million)
  • Table 62. Global Cell Freezing Media Revenue Market Share by Region (2021-2026)
  • Table 63. Global Cell Freezing Media Revenue Market Share by Region (2027-2032)
  • Table 64. Thermo Fisher Scientific Company Information
  • Table 65. Thermo Fisher Scientific Business Overview
  • Table 66. Thermo Fisher Scientific Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 67. Thermo Fisher Scientific Cell Freezing Media Product Portfolio
  • Table 68. Thermo Fisher Scientific Recent Development
  • Table 69. Merck Company Information
  • Table 70. Merck Business Overview
  • Table 71. Merck Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 72. Merck Cell Freezing Media Product Portfolio
  • Table 73. Merck Recent Development
  • Table 74. Cytiva Company Information
  • Table 75. Cytiva Business Overview
  • Table 76. Cytiva Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 77. Cytiva Cell Freezing Media Product Portfolio
  • Table 78. Cytiva Recent Development
  • Table 79. Sartorius Company Information
  • Table 80. Sartorius Business Overview
  • Table 81. Sartorius Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 82. Sartorius Cell Freezing Media Product Portfolio
  • Table 83. Sartorius Recent Development
  • Table 84. FUJIFILM Company Information
  • Table 85. FUJIFILM Business Overview
  • Table 86. FUJIFILM Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 87. FUJIFILM Cell Freezing Media Product Portfolio
  • Table 88. FUJIFILM Recent Development
  • Table 89. BioLife Solutions Company Information
  • Table 90. BioLife Solutions Business Overview
  • Table 91. BioLife Solutions Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 92. BioLife Solutions Cell Freezing Media Product Portfolio
  • Table 93. BioLife Solutions Recent Development
  • Table 94. Lonza Company Information
  • Table 95. Lonza Business Overview
  • Table 96. Lonza Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 97. Lonza Cell Freezing Media Product Portfolio
  • Table 98. Lonza Recent Development
  • Table 99. STEMCELL Technologies Company Information
  • Table 100. STEMCELL Technologies Business Overview
  • Table 101. STEMCELL Technologies Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 102. STEMCELL Technologies Cell Freezing Media Product Portfolio
  • Table 103. STEMCELL Technologies Recent Development
  • Table 104. Miltenyi Biotec Company Information
  • Table 105. Miltenyi Biotec Business Overview
  • Table 106. Miltenyi Biotec Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 107. Miltenyi Biotec Cell Freezing Media Product Portfolio
  • Table 108. Miltenyi Biotec Recent Development
  • Table 109. Bio Techne Company Information
  • Table 110. Bio Techne Business Overview
  • Table 111. Bio Techne Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 112. Bio Techne Cell Freezing Media Product Portfolio
  • Table 113. Bio Techne Recent Development
  • Table 114. Avantor Company Information
  • Table 115. Avantor Business Overview
  • Table 116. Avantor Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 117. Avantor Cell Freezing Media Product Portfolio
  • Table 118. Avantor Recent Development
  • Table 119. HiMedia Laboratories Company Information
  • Table 120. HiMedia Laboratories Business Overview
  • Table 121. HiMedia Laboratories Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 122. HiMedia Laboratories Cell Freezing Media Product Portfolio
  • Table 123. HiMedia Laboratories Recent Development
  • Table 124. ZENOAQ Company Information
  • Table 125. ZENOAQ Business Overview
  • Table 126. ZENOAQ Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 127. ZENOAQ Cell Freezing Media Product Portfolio
  • Table 128. ZENOAQ Recent Development
  • Table 129. PAN Biotech Company Information
  • Table 130. PAN Biotech Business Overview
  • Table 131. PAN Biotech Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 132. PAN Biotech Cell Freezing Media Product Portfolio
  • Table 133. PAN Biotech Recent Development
  • Table 134. PromoCell Company Information
  • Table 135. PromoCell Business Overview
  • Table 136. PromoCell Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 137. PromoCell Cell Freezing Media Product Portfolio
  • Table 138. PromoCell Recent Development
  • Table 139. MP Biomedicals Company Information
  • Table 140. MP Biomedicals Business Overview
  • Table 141. MP Biomedicals Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 142. MP Biomedicals Cell Freezing Media Product Portfolio
  • Table 143. MP Biomedicals Recent Development
  • Table 144. ATCC Company Information
  • Table 145. ATCC Business Overview
  • Table 146. ATCC Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 147. ATCC Cell Freezing Media Product Portfolio
  • Table 148. ATCC Recent Development
  • Table 149. Teknova Company Information
  • Table 150. Teknova Business Overview
  • Table 151. Teknova Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 152. Teknova Cell Freezing Media Product Portfolio
  • Table 153. Teknova Recent Development
  • Table 154. Yocon Biotechnology Company Information
  • Table 155. Yocon Biotechnology Business Overview
  • Table 156. Yocon Biotechnology Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 157. Yocon Biotechnology Cell Freezing Media Product Portfolio
  • Table 158. Yocon Biotechnology Recent Development
  • Table 159. ExCell Bio Company Information
  • Table 160. ExCell Bio Business Overview
  • Table 161. ExCell Bio Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 162. ExCell Bio Cell Freezing Media Product Portfolio
  • Table 163. ExCell Bio Recent Development
  • Table 164. Shanghai BasalMedia Company Information
  • Table 165. Shanghai BasalMedia Business Overview
  • Table 166. Shanghai BasalMedia Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 167. Shanghai BasalMedia Cell Freezing Media Product Portfolio
  • Table 168. Shanghai BasalMedia Recent Development
  • Table 169. Dakewe Company Information
  • Table 170. Dakewe Business Overview
  • Table 171. Dakewe Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 172. Dakewe Cell Freezing Media Product Portfolio
  • Table 173. Dakewe Recent Development
  • Table 174. Cyagen Biosciences Company Information
  • Table 175. Cyagen Biosciences Business Overview
  • Table 176. Cyagen Biosciences Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 177. Cyagen Biosciences Cell Freezing Media Product Portfolio
  • Table 178. Cyagen Biosciences Recent Development
  • Table 179. Yeasen Biotechnology Company Information
  • Table 180. Yeasen Biotechnology Business Overview
  • Table 181. Yeasen Biotechnology Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 182. Yeasen Biotechnology Cell Freezing Media Product Portfolio
  • Table 183. Yeasen Biotechnology Recent Development
  • Table 184. Solarbio Company Information
  • Table 185. Solarbio Business Overview
  • Table 186. Solarbio Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 187. Solarbio Cell Freezing Media Product Portfolio
  • Table 188. Solarbio Recent Development
  • Table 189. Beyotime Biotechnology Company Information
  • Table 190. Beyotime Biotechnology Business Overview
  • Table 191. Beyotime Biotechnology Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 192. Beyotime Biotechnology Cell Freezing Media Product Portfolio
  • Table 193. Beyotime Biotechnology Recent Development
  • Table 194. Quality Biological Company Information
  • Table 195. Quality Biological Business Overview
  • Table 196. Quality Biological Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 197. Quality Biological Cell Freezing Media Product Portfolio
  • Table 198. Quality Biological Recent Development
  • Table 199. WELGENE Company Information
  • Table 200. WELGENE Business Overview
  • Table 201. WELGENE Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 202. WELGENE Cell Freezing Media Product Portfolio
  • Table 203. WELGENE Recent Development
  • Table 204. GC Lymphotec Company Information
  • Table 205. GC Lymphotec Business Overview
  • Table 206. GC Lymphotec Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 207. GC Lymphotec Cell Freezing Media Product Portfolio
  • Table 208. GC Lymphotec Recent Development
  • Table 209. Capricorn Scientific Company Information
  • Table 210. Capricorn Scientific Business Overview
  • Table 211. Capricorn Scientific Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 212. Capricorn Scientific Cell Freezing Media Product Portfolio
  • Table 213. Capricorn Scientific Recent Development
  • Table 214. Meilun Biotechnology Company Information
  • Table 215. Meilun Biotechnology Business Overview
  • Table 216. Meilun Biotechnology Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 217. Meilun Biotechnology Cell Freezing Media Product Portfolio
  • Table 218. Meilun Biotechnology Recent Development
  • Table 219. Nacalai Tesque Company Information
  • Table 220. Nacalai Tesque Business Overview
  • Table 221. Nacalai Tesque Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 222. Nacalai Tesque Cell Freezing Media Product Portfolio
  • Table 223. Nacalai Tesque Recent Development
  • Table 224. Saraya Company Information
  • Table 225. Saraya Business Overview
  • Table 226. Saraya Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 227. Saraya Cell Freezing Media Product Portfolio
  • Table 228. Saraya Recent Development
  • Table 229. ScienCell Research Laboratories Company Information
  • Table 230. ScienCell Research Laboratories Business Overview
  • Table 231. ScienCell Research Laboratories Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 232. ScienCell Research Laboratories Cell Freezing Media Product Portfolio
  • Table 233. ScienCell Research Laboratories Recent Development
  • Table 234. Cell Applications Company Information
  • Table 235. Cell Applications Business Overview
  • Table 236. Cell Applications Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 237. Cell Applications Cell Freezing Media Product Portfolio
  • Table 238. Cell Applications Recent Development
  • Table 239. Nanjing Sansheng Biotechnology Company Information
  • Table 240. Nanjing Sansheng Biotechnology Business Overview
  • Table 241. Nanjing Sansheng Biotechnology Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 242. Nanjing Sansheng Biotechnology Cell Freezing Media Product Portfolio
  • Table 243. Nanjing Sansheng Biotechnology Recent Development
  • Table 244. Pricella Biotechnology Company Information
  • Table 245. Pricella Biotechnology Business Overview
  • Table 246. Pricella Biotechnology Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 247. Pricella Biotechnology Cell Freezing Media Product Portfolio
  • Table 248. Pricella Biotechnology Recent Development
  • Table 249. CELLnTEC Company Information
  • Table 250. CELLnTEC Business Overview
  • Table 251. CELLnTEC Cell Freezing Media Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 252. CELLnTEC Cell Freezing Media Product Portfolio
  • Table 253. CELLnTEC Recent Development
  • Table 254. Key Raw Materials
  • Table 255. Raw Materials Key Suppliers
  • Table 256. Cell Freezing Media Distributors List
  • Table 257. Cell Freezing Media Customers List
  • Table 258. Research Programs/Design for This Report
  • Table 259. Authors List of This Report
  • Table 260. Secondary Sources
  • Table 261. Primary Sources

List of Figures

  • Figure 1. Cell Freezing Media Product Image
  • Figure 2. Global Cell Freezing Media Market Size (US$ Million), 2021 VS 2025 VS 2032
  • Figure 3. Global Cell Freezing Media Market Size (2021-2032) & (US$ Million)
  • Figure 4. Global Cell Freezing Media Sales (2021-2032) & (L)
  • Figure 5. Global Cell Freezing Media Average Price (USD/L) & (2021-2032)
  • Figure 6. Global Top 5 and 10 Cell Freezing Media Players Market Share by Revenue in 2025
  • Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
  • Figure 8. DMSO Containing Image
  • Figure 9. DMSO Free Image
  • Figure 10. Global Cell Freezing Media Sales by Type (2021 VS 2025 VS 2032) & (L)
  • Figure 11. Global Cell Freezing Media Sales Market Share 2021 VS 2025 VS 2032
  • Figure 12. Global Cell Freezing Media Sales Market Share by Type (2021-2032)
  • Figure 13. Global Cell Freezing Media Revenue by Type (2021 VS 2025 VS 2032) & (L)
  • Figure 14. Global Cell Freezing Media Revenue Market Share 2021 VS 2025 VS 2032
  • Figure 15. Global Cell Freezing Media Revenue Market Share by Type (2021-2032)
  • Figure 16. Research Image
  • Figure 17. Biobanking Image
  • Figure 18. Biopharmaceutical Manufacturing Image
  • Figure 19. Cell Therapy and Regenerative Medicine Image
  • Figure 20. Global Cell Freezing Media Sales by Application (2021 VS 2025 VS 2032) & (L)
  • Figure 21. Global Cell Freezing Media Sales Market Share 2021 VS 2025 VS 2032
  • Figure 22. Global Cell Freezing Media Sales Market Share by Application (2021-2032)
  • Figure 23. Global Cell Freezing Media Revenue by Application (2021 VS 2025 VS 2032) & (L)
  • Figure 24. Global Cell Freezing Media Revenue Market Share 2021 VS 2025 VS 2032
  • Figure 25. Global Cell Freezing Media Revenue Market Share by Application (2021-2032)
  • Figure 26. North America Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 27. North America Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 28. U.S. Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 29. Canada Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 30. Mexico Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 31. Europe Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 32. Europe Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 33. Germany Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 34. France Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 35. U.K. Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 36. Italy Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 37. Netherlands Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 38. Asia Pacific Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 39. Asia Pacific Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 40. China Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 41. Japan Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 42. South Korea Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 43. Southeast Asia Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 44. India Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 45. Australia Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 46. South America, Middle East and Africa Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 47. South America, Middle East and Africa Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 48. Brazil Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 49. South Africa Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 50. Saudi Arabia Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 51. Turkey Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 52. Argentina Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 53. UAE Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 54. Egypt Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 55. Chile Cell Freezing Media Sales and Growth Rate (2021-2032) & (L)
  • Figure 56. Global Cell Freezing Media Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
  • Figure 57. Global Cell Freezing Media Revenue Market Share by Region in Percentage: 2025 Versus 2032
  • Figure 58. North America Cell Freezing Media Revenue (2021-2032) & (US$ Million)
  • Figure 59. North America Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
  • Figure 60. Europe Cell Freezing Media Revenue (2021-2032) & (US$ Million)
  • Figure 61. Europe Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
  • Figure 62. Asia-Pacific Cell Freezing Media Revenue (2021-2032) & (US$ Million)
  • Figure 63. Asia-Pacific Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
  • Figure 64. South America, Middle East and Africa Cell Freezing Media Revenue (2021-2032) & (US$ Million)
  • Figure 65. South America, Middle East and Africa Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
  • Figure 66. Cell Freezing Media Value Chain
  • Figure 67. Manufacturing Cost Structure
  • Figure 68. Cell Freezing Media Production Mode & Process
  • Figure 69. Direct Comparison with Distribution Share
  • Figure 70. Distributors Profiles
  • Figure 71. Years Considered
  • Figure 72. Research Process
  • Figure 73. Key Executives Interviewed

Scope & coverage.

By Type
  • DMSO Containing
  • DMSO Free
By Application
  • Research
  • Biobanking
  • Biopharmaceutical Manufacturing
  • Cell Therapy and Regenerative Medicine
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Cytiva
  • Sartorius
  • FUJIFILM
  • BioLife Solutions
  • Lonza
  • STEMCELL Technologies
  • Miltenyi Biotec
  • Bio Techne
  • Avantor
  • HiMedia Laboratories
  • ZENOAQ
  • PAN Biotech
  • PromoCell
  • MP Biomedicals
  • ATCC
  • Teknova
  • Yocon Biotechnology
  • ExCell Bio
  • Shanghai BasalMedia
  • Dakewe
  • Cyagen Biosciences
  • Yeasen Biotechnology
  • Solarbio
  • Beyotime Biotechnology
  • Quality Biological
  • WELGENE
  • GC Lymphotec
  • Capricorn Scientific
  • Meilun Biotechnology
  • Nacalai Tesque
  • Saraya
  • ScienCell Research Laboratories
  • Cell Applications
  • Nanjing Sansheng Biotechnology
  • Pricella Biotechnology
  • CELLnTEC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell Freezing Media Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell Freezing Media Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cell Freezing Media Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cell Freezing Media Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cell Freezing Media Market Dynamics
  1. 2.1 Cell Freezing Media Industry Trends
  2. 2.2 Cell Freezing Media Industry Drivers
  3. 2.3 Cell Freezing Media Industry Opportunities and Challenges
  4. 2.4 Cell Freezing Media Industry Restraints
3 Cell Freezing Media Market by Manufacturers
  1. 3.1 Global Cell Freezing Media Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cell Freezing Media Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cell Freezing Media Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cell Freezing Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cell Freezing Media Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cell Freezing Media Manufacturers, Product Type & Application
  7. 3.7 Global Cell Freezing Media Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cell Freezing Media Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cell Freezing Media Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cell Freezing Media Tier 1, Tier 2, and Tier 3
4 Cell Freezing Media Market by Type
  1. 4.1 Cell Freezing Media Type Introduction
  2. 4.1.1 DMSO Containing
  3. 4.1.2 DMSO Free
  4. 4.2 Global Cell Freezing Media Sales by Type
  5. 4.2.1 Global Cell Freezing Media Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cell Freezing Media Sales by Type (2021-2032)
  7. 4.2.3 Global Cell Freezing Media Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cell Freezing Media Revenue by Type
  9. 4.3.1 Global Cell Freezing Media Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cell Freezing Media Revenue by Type (2021-2032)
  11. 4.3.3 Global Cell Freezing Media Revenue Market Share by Type (2021-2032)
5 Cell Freezing Media Market by Application
  1. 5.1 Cell Freezing Media Application Introduction
  2. 5.1.1 Research
  3. 5.1.2 Biobanking
  4. 5.1.3 Biopharmaceutical Manufacturing
  5. 5.1.4 Cell Therapy and Regenerative Medicine
  6. 5.2 Global Cell Freezing Media Sales by Application
  7. 5.2.1 Global Cell Freezing Media Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cell Freezing Media Sales by Application (2021-2032)
  9. 5.2.3 Global Cell Freezing Media Sales Market Share by Application (2021-2032)
  10. 5.3 Global Cell Freezing Media Revenue by Application
  11. 5.3.1 Global Cell Freezing Media Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cell Freezing Media Revenue by Application (2021-2032)
  13. 5.3.3 Global Cell Freezing Media Revenue Market Share by Application (2021-2032)
6 Global Cell Freezing Media Sales by Region
  1. 6.1 Global Cell Freezing Media Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell Freezing Media Sales by Region (2021-2032)
  3. 6.2.1 Global Cell Freezing Media Sales by Region (2021-2026)
  4. 6.2.2 Global Cell Freezing Media Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cell Freezing Media Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cell Freezing Media Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cell Freezing Media Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cell Freezing Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cell Freezing Media Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.7 Argentina
  36. 6.6.8 UAE
  37. 6.6.9 Egypt
  38. 6.6.10 Chile
7 Global Cell Freezing Media Revenue by Region
  1. 7.1 Global Cell Freezing Media Revenue by Region
  2. 7.1.1 Global Cell Freezing Media Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cell Freezing Media Revenue by Region (2021-2026)
  4. 7.1.3 Global Cell Freezing Media Revenue by Region (2027-2032)
  5. 7.1.4 Global Cell Freezing Media Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cell Freezing Media Revenue (2021-2032)
  8. 7.2.2 North America Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cell Freezing Media Revenue (2021-2032)
  11. 7.3.2 Europe Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cell Freezing Media Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cell Freezing Media Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cell Freezing Media Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Cell Freezing Media Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Cell Freezing Media Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Cytiva
  14. 8.3.1 Cytiva Company Information
  15. 8.3.2 Cytiva Business Overview
  16. 8.3.3 Cytiva Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cytiva Cell Freezing Media Product Portfolio
  18. 8.3.5 Cytiva Recent Developments
  19. 8.4 Sartorius
  20. 8.4.1 Sartorius Company Information
  21. 8.4.2 Sartorius Business Overview
  22. 8.4.3 Sartorius Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sartorius Cell Freezing Media Product Portfolio
  24. 8.4.5 Sartorius Recent Developments
  25. 8.5 FUJIFILM
  26. 8.5.1 FUJIFILM Company Information
  27. 8.5.2 FUJIFILM Business Overview
  28. 8.5.3 FUJIFILM Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 FUJIFILM Cell Freezing Media Product Portfolio
  30. 8.5.5 FUJIFILM Recent Developments
  31. 8.6 BioLife Solutions
  32. 8.6.1 BioLife Solutions Company Information
  33. 8.6.2 BioLife Solutions Business Overview
  34. 8.6.3 BioLife Solutions Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BioLife Solutions Cell Freezing Media Product Portfolio
  36. 8.6.5 BioLife Solutions Recent Developments
  37. 8.7 Lonza
  38. 8.7.1 Lonza Company Information
  39. 8.7.2 Lonza Business Overview
  40. 8.7.3 Lonza Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lonza Cell Freezing Media Product Portfolio
  42. 8.7.5 Lonza Recent Developments
  43. 8.8 STEMCELL Technologies
  44. 8.8.1 STEMCELL Technologies Company Information
  45. 8.8.2 STEMCELL Technologies Business Overview
  46. 8.8.3 STEMCELL Technologies Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 STEMCELL Technologies Cell Freezing Media Product Portfolio
  48. 8.8.5 STEMCELL Technologies Recent Developments
  49. 8.9 Miltenyi Biotec
  50. 8.9.1 Miltenyi Biotec Company Information
  51. 8.9.2 Miltenyi Biotec Business Overview
  52. 8.9.3 Miltenyi Biotec Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Miltenyi Biotec Cell Freezing Media Product Portfolio
  54. 8.9.5 Miltenyi Biotec Recent Developments
  55. 8.10 Bio Techne
  56. 8.10.1 Bio Techne Company Information
  57. 8.10.2 Bio Techne Business Overview
  58. 8.10.3 Bio Techne Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bio Techne Cell Freezing Media Product Portfolio
  60. 8.10.5 Bio Techne Recent Developments
  61. 8.11 Avantor
  62. 8.11.1 Avantor Company Information
  63. 8.11.2 Avantor Business Overview
  64. 8.11.3 Avantor Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Avantor Cell Freezing Media Product Portfolio
  66. 8.11.5 Avantor Recent Developments
  67. 8.12 HiMedia Laboratories
  68. 8.12.1 HiMedia Laboratories Company Information
  69. 8.12.2 HiMedia Laboratories Business Overview
  70. 8.12.3 HiMedia Laboratories Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HiMedia Laboratories Cell Freezing Media Product Portfolio
  72. 8.12.5 HiMedia Laboratories Recent Developments
  73. 8.13 ZENOAQ
  74. 8.13.1 ZENOAQ Company Information
  75. 8.13.2 ZENOAQ Business Overview
  76. 8.13.3 ZENOAQ Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ZENOAQ Cell Freezing Media Product Portfolio
  78. 8.13.5 ZENOAQ Recent Developments
  79. 8.14 PAN Biotech
  80. 8.14.1 PAN Biotech Company Information
  81. 8.14.2 PAN Biotech Business Overview
  82. 8.14.3 PAN Biotech Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 PAN Biotech Cell Freezing Media Product Portfolio
  84. 8.14.5 PAN Biotech Recent Developments
  85. 8.15 PromoCell
  86. 8.15.1 PromoCell Company Information
  87. 8.15.2 PromoCell Business Overview
  88. 8.15.3 PromoCell Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PromoCell Cell Freezing Media Product Portfolio
  90. 8.15.5 PromoCell Recent Developments
  91. 8.16 MP Biomedicals
  92. 8.16.1 MP Biomedicals Company Information
  93. 8.16.2 MP Biomedicals Business Overview
  94. 8.16.3 MP Biomedicals Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 MP Biomedicals Cell Freezing Media Product Portfolio
  96. 8.16.5 MP Biomedicals Recent Developments
  97. 8.17 ATCC
  98. 8.17.1 ATCC Company Information
  99. 8.17.2 ATCC Business Overview
  100. 8.17.3 ATCC Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ATCC Cell Freezing Media Product Portfolio
  102. 8.17.5 ATCC Recent Developments
  103. 8.18 Teknova
  104. 8.18.1 Teknova Company Information
  105. 8.18.2 Teknova Business Overview
  106. 8.18.3 Teknova Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Teknova Cell Freezing Media Product Portfolio
  108. 8.18.5 Teknova Recent Developments
  109. 8.19 Yocon Biotechnology
  110. 8.19.1 Yocon Biotechnology Company Information
  111. 8.19.2 Yocon Biotechnology Business Overview
  112. 8.19.3 Yocon Biotechnology Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Yocon Biotechnology Cell Freezing Media Product Portfolio
  114. 8.19.5 Yocon Biotechnology Recent Developments
  115. 8.20 ExCell Bio
  116. 8.20.1 ExCell Bio Company Information
  117. 8.20.2 ExCell Bio Business Overview
  118. 8.20.3 ExCell Bio Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 ExCell Bio Cell Freezing Media Product Portfolio
  120. 8.20.5 ExCell Bio Recent Developments
  121. 8.21 Shanghai BasalMedia
  122. 8.21.1 Shanghai BasalMedia Company Information
  123. 8.21.2 Shanghai BasalMedia Business Overview
  124. 8.21.3 Shanghai BasalMedia Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Shanghai BasalMedia Cell Freezing Media Product Portfolio
  126. 8.21.5 Shanghai BasalMedia Recent Developments
  127. 8.22 Dakewe
  128. 8.22.1 Dakewe Company Information
  129. 8.22.2 Dakewe Business Overview
  130. 8.22.3 Dakewe Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Dakewe Cell Freezing Media Product Portfolio
  132. 8.22.5 Dakewe Recent Developments
  133. 8.23 Cyagen Biosciences
  134. 8.23.1 Cyagen Biosciences Company Information
  135. 8.23.2 Cyagen Biosciences Business Overview
  136. 8.23.3 Cyagen Biosciences Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Cyagen Biosciences Cell Freezing Media Product Portfolio
  138. 8.23.5 Cyagen Biosciences Recent Developments
  139. 8.24 Yeasen Biotechnology
  140. 8.24.1 Yeasen Biotechnology Company Information
  141. 8.24.2 Yeasen Biotechnology Business Overview
  142. 8.24.3 Yeasen Biotechnology Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Yeasen Biotechnology Cell Freezing Media Product Portfolio
  144. 8.24.5 Yeasen Biotechnology Recent Developments
  145. 8.25 Solarbio
  146. 8.25.1 Solarbio Company Information
  147. 8.25.2 Solarbio Business Overview
  148. 8.25.3 Solarbio Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Solarbio Cell Freezing Media Product Portfolio
  150. 8.25.5 Solarbio Recent Developments
  151. 8.26 Beyotime Biotechnology
  152. 8.26.1 Beyotime Biotechnology Company Information
  153. 8.26.2 Beyotime Biotechnology Business Overview
  154. 8.26.3 Beyotime Biotechnology Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Beyotime Biotechnology Cell Freezing Media Product Portfolio
  156. 8.26.5 Beyotime Biotechnology Recent Developments
  157. 8.27 Quality Biological
  158. 8.27.1 Quality Biological Company Information
  159. 8.27.2 Quality Biological Business Overview
  160. 8.27.3 Quality Biological Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Quality Biological Cell Freezing Media Product Portfolio
  162. 8.27.5 Quality Biological Recent Developments
  163. 8.28 WELGENE
  164. 8.28.1 WELGENE Company Information
  165. 8.28.2 WELGENE Business Overview
  166. 8.28.3 WELGENE Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 WELGENE Cell Freezing Media Product Portfolio
  168. 8.28.5 WELGENE Recent Developments
  169. 8.29 GC Lymphotec
  170. 8.29.1 GC Lymphotec Company Information
  171. 8.29.2 GC Lymphotec Business Overview
  172. 8.29.3 GC Lymphotec Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  173. 8.29.4 GC Lymphotec Cell Freezing Media Product Portfolio
  174. 8.29.5 GC Lymphotec Recent Developments
  175. 8.30 Capricorn Scientific
  176. 8.30.1 Capricorn Scientific Company Information
  177. 8.30.2 Capricorn Scientific Business Overview
  178. 8.30.3 Capricorn Scientific Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Capricorn Scientific Cell Freezing Media Product Portfolio
  180. 8.30.5 Capricorn Scientific Recent Developments
  181. 8.31 Meilun Biotechnology
  182. 8.31.1 Meilun Biotechnology Company Information
  183. 8.31.2 Meilun Biotechnology Business Overview
  184. 8.31.3 Meilun Biotechnology Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Meilun Biotechnology Cell Freezing Media Product Portfolio
  186. 8.31.5 Meilun Biotechnology Recent Developments
  187. 8.32 Nacalai Tesque
  188. 8.32.1 Nacalai Tesque Company Information
  189. 8.32.2 Nacalai Tesque Business Overview
  190. 8.32.3 Nacalai Tesque Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Nacalai Tesque Cell Freezing Media Product Portfolio
  192. 8.32.5 Nacalai Tesque Recent Developments
  193. 8.33 Saraya
  194. 8.33.1 Saraya Company Information
  195. 8.33.2 Saraya Business Overview
  196. 8.33.3 Saraya Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Saraya Cell Freezing Media Product Portfolio
  198. 8.33.5 Saraya Recent Developments
  199. 8.34 ScienCell Research Laboratories
  200. 8.34.1 ScienCell Research Laboratories Company Information
  201. 8.34.2 ScienCell Research Laboratories Business Overview
  202. 8.34.3 ScienCell Research Laboratories Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  203. 8.34.4 ScienCell Research Laboratories Cell Freezing Media Product Portfolio
  204. 8.34.5 ScienCell Research Laboratories Recent Developments
  205. 8.35 Cell Applications
  206. 8.35.1 Cell Applications Company Information
  207. 8.35.2 Cell Applications Business Overview
  208. 8.35.3 Cell Applications Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Cell Applications Cell Freezing Media Product Portfolio
  210. 8.35.5 Cell Applications Recent Developments
  211. 8.36 Nanjing Sansheng Biotechnology
  212. 8.36.1 Nanjing Sansheng Biotechnology Company Information
  213. 8.36.2 Nanjing Sansheng Biotechnology Business Overview
  214. 8.36.3 Nanjing Sansheng Biotechnology Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  215. 8.36.4 Nanjing Sansheng Biotechnology Cell Freezing Media Product Portfolio
  216. 8.36.5 Nanjing Sansheng Biotechnology Recent Developments
  217. 8.37 Pricella Biotechnology
  218. 8.37.1 Pricella Biotechnology Company Information
  219. 8.37.2 Pricella Biotechnology Business Overview
  220. 8.37.3 Pricella Biotechnology Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  221. 8.37.4 Pricella Biotechnology Cell Freezing Media Product Portfolio
  222. 8.37.5 Pricella Biotechnology Recent Developments
  223. 8.38 CELLnTEC
  224. 8.38.1 CELLnTEC Company Information
  225. 8.38.2 CELLnTEC Business Overview
  226. 8.38.3 CELLnTEC Cell Freezing Media Sales, Price, Revenue and Gross Margin (2021-2026)
  227. 8.38.4 CELLnTEC Cell Freezing Media Product Portfolio
  228. 8.38.5 CELLnTEC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cell Freezing Media Value Chain Analysis
  2. 9.1.1 Cell Freezing Media Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cell Freezing Media Production Mode & Process
  6. 9.2 Cell Freezing Media Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cell Freezing Media Distributors
  9. 9.2.3 Cell Freezing Media Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.